Abeona Therapeutics, Inc. (ABEO)
4.41
-0.02
(-0.45%)
USD |
NASDAQ |
Oct 19, 16:00
4.41
0.00 (0.00%)
After-Hours: 20:00
Abeona Therapeutics EPS Diluted (Quarterly) : -0.3539 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3539 |
| March 31, 2026 | -0.3016 |
| December 31, 2025 | -0.3717 |
| September 30, 2025 | -0.0952 |
| June 30, 2025 | 1.706 |
| March 31, 2025 | -0.2416 |
| December 31, 2024 | -0.2036 |
| September 30, 2024 | -0.6295 |
| June 30, 2024 | -0.2625 |
| March 31, 2024 | -1.156 |
| December 31, 2023 | -0.6492 |
| September 30, 2023 | -0.4773 |
| June 30, 2023 | -0.9243 |
| March 31, 2023 | -0.5387 |
| December 31, 2022 | -0.0636 |
| September 30, 2022 | -1.002 |
| June 30, 2022 | -1.357 |
| March 31, 2022 | -95.10 |
| December 31, 2021 | -11.15 |
| September 30, 2021 | -1.797 |
| June 30, 2021 | -3.939 |
| March 31, 2021 | -4.245 |
| December 31, 2020 | -4.261 |
| September 30, 2020 | -1.930 |
| June 30, 2020 | -3.490 |
| Date | Value |
|---|---|
| March 31, 2020 | -13.00 |
| December 31, 2019 | -7.507 |
| September 30, 2019 | -8.734 |
| June 30, 2019 | -12.22 |
| March 31, 2019 | -9.674 |
| September 30, 2018 | -8.588 |
| June 30, 2018 | -6.470 |
| March 31, 2018 | -5.594 |
| December 31, 2017 | -4.75 |
| September 30, 2017 | -3.25 |
| June 30, 2017 | -5.25 |
| March 31, 2017 | -3.25 |
| December 31, 2016 | -4.75 |
| September 30, 2016 | -2.00 |
| June 30, 2016 | -5.00 |
| March 31, 2016 | -4.25 |
| December 31, 2015 | -1.75 |
| September 30, 2015 | -4.75 |
| June 30, 2015 | -4.00 |
| March 31, 2015 | -2.50 |
| December 31, 2014 | -15.81 |
| September 30, 2014 | -103.75 |
| June 30, 2014 | -637.50 |
| March 31, 2014 | -75.00 |
| December 31, 2013 | -87.50 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ultragenyx Pharmaceutical, Inc. | -0.9028 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.19M |
| Revenue (Quarterly) | 11.38M |
| Total Expenses (Quarterly) | 31.57M |
| Enterprise Value | 126.56M |
| Gross Profit Margin (Quarterly) | 57.45% |
| Profit Margin (Quarterly) | -177.4% |
| Earnings Yield | -25.45% |
| Normalized Earnings Yield | -26.21 |